{"id":1287,"title":"[Medication adherence with the fixed combination of ramipril and amlodipine].","abstract":"Bevezetés: Az olyan krónikus betegségek, mint a hypertonia kezelése során is kiemelked? jelent?séggel bír a megfelel? betegadherencia, mivel csak tartós és hatásos gyógyszerszedés segítségével érhet? el a célvérnyomás és a cardiovascularis kockázat csökkenése. Jól ismert, hogy a hypertonia az egyik legfontosabb cardiovascularis kockázati tényez?. Nemzetközi adatok szerint a fix kombinációval végzett antihipertenzív terápia mintegy 20%-kal javítja a betegadherenciát a szabad kombinációhoz képest. Célkit?zés: A szerz?k célja a hypertoniaindikációban indított ramipril és amlodipin szabad és fix kombinációk egyéves perzisztenciájának összehasonlítása volt. Módszer: Az Országos Egészségbiztosítási Pénztár adatbázisából a vényforgalmi adatokra támaszkodva hypertoniaindikációban, 2012. október 1. és 2013. szeptember 30. között els? alkalommal ramipril és amlodipin szabad, illetve ramipril és amlodipin fix kombináció receptjeit kiváltó betegeket választották ki, akik az ezt megel?z? egy évben hasonló hatóanyaggal végzett antihipertenzív terápiában nem részesültek. A perzisztenciagörbéket Kaplan–Meier-becsléssel határozták meg, 95%-os, log-skálán számolt pontonkénti konfidenciaintervallummal. Cenzoráltnak azokat a betegeket vették, akik a vizsgálat záró id?pontjában is perzisztensek voltak. A görbék modellezéséhez félparaméteres eljárást, Cox-regressziót használtak, ahol az egyetlen – kategoriális – magyarázó változó a terápia volt; referenciacsoportnak a fix kombinációt vették. Eredmények: A vizsgált id?szakban 20 096 beteg kezdett ramipril és amlodipin szabad kombinációs, míg 10 449 beteg kezdett ramipril és amlodipin fix kombinációs antihipertenzív terápiát. A megfigyelési id?szakban a ramipril és az amlodipin szabad kombinációja esetén az egyéves perzisztencia 34%-os volt, míg a fix kombinációt szed?knél ez 54%-nak adódott, azaz 20%-os volt a különbség, ami 58,8/2%-kal magasabb perzisztenciát jelent. A 360 napra korlátozott átlagos perzisztencia id?tartama 272 nap volt a fix, míg 206 nap a szabad kombinációt szed? csoportban. A szabad és a fix kombinációs kezelés perzisztenciáját Cox regressziós analízissel vizsgálva azt találták, hogy a szabad kombináció esetén mintegy kétszeres a gyógyszerelhagyás pillanatnyi rátája a fix kombinációhoz képest (kockázat arány = 1,94, p<0,001). Következtetések: A nemzetközi viszonylatban is egyedülálló vizsgálatukban igazolták, hogy a hypertoniaindikációban ramipril és amlodipin szabad és fix kombinációs terápia közül egyértelm?en el?nyösebb a fix kombinációs készítmény, mivel ebben az esetben a gyógyszerelhagyás esélye mintegy fele a szabad kombinációhoz képest az egyéves követési id?szak alatt. Tekintettel arra, hogy a nem megfelel?en kezelt hypertonia jelent?s cardiovascularis kockázati tényez?, a ramipril/amlodipin fix kombinációval végzett terápia kifejezetten nagyobb perzisztenciája hosszabb távon népegészségügyileg is jelent?s cardiovascularis kockázatcsökkenést eredményezhet. Orv. Hetil., 2014, 155(47), 1882–1888.Adequate patient adherence has outstanding importance during the management of chronic disorders including hypertension. In particular, target blood pressure and reduction of cardiovascular risk can be reached only by prolonged, effective pharmacotherapy. Hypertension is known as one of the most significant cardiovascular risk factors. According to international data, antihypertensive therapy with a fixed combination improves patient adherence by about 20 per cent in comparison with free combinations.The aim of the study was to evaluate the persistence on one-year treatment with the free or fixed combination of ramipril and amlodipine, administered for the indication of hypertension.Information from the National Health Insurance Found prescriptions database, on pharmacy-claims between October 1, 2012 and September 30, 2013 was analyzed. The authors identified patients who filled prescriptions for fixed or free combinations of ramipril and amlodipine, prescribed for the first time, for the therapeutic indication of hypertension. The subjects have not received antihypertensive therapy with similar active substances during the year preceding the study. Using the Kaplan-Meier technique, the authors constructed persistence curves with a 95% confidence interval for point estimates calculated on a log scale. Patients who were still persistent at the closing date of the study were considered censored. For modeling of the curves, the authors used semi-parametric Cox's regression where antihypertensive therapy was the only (categorical) explanatory variable, and the patients taking the fixed combination were regarded as the reference group.During the study period, combination antihypertensive therapy with ramipril and amlodipine was started with a free or a fixed combination of these agents in 20,096 and 10,449 patients, respectively. One-year persistence rate in patients taking ramipril and amlodipine as a free combination was 34%, whereas 54% in those on the fixed combination. This 20 percent difference means that the rate of persistence was higher by 58.8/2%. Considering only the 360-day study period, the mean duration of persistence was 272 days in patients on the fixed, and 206 days in those taking the free combination. Analyzing persistence on treatment with these combinations showed that the actual rate of discontinuation was about twice higher during treatment with the free, compared with the use of the fixed combination (hazard ratio = 1.94, p<0.001).This study, which is unique even by international standards, demonstrated the clear benefit of initiating antihypertensive therapy with the fixed combination of ramipril and amlodipine over starting treatment with the free combination. In particular, the chance of discontinuation during a one-year treatment with the former was approximately half of that seen with the latter. Inadequately controlled hypertension is a significant cardiovascular risk factor. The markedly higher persistence of patients on therapy with the fixed combination of ramipril and amlodipine can lead to a reduction in cardiovascular risk, which might prove - on the longer term - a positive outcome of public health significance.","date":"2014-11-18","categories":"Cardiovascular Diseases","split":"train","url":"http://www.ncbi.nlm.nih.gov/pubmed/25403283","annotations":[{"name":"Confidence interval","weight":0.842185,"wikipedia_article":"http://en.wikipedia.org/wiki/Confidence_interval"},{"name":"Hypertension","weight":0.812713,"wikipedia_article":"http://en.wikipedia.org/wiki/Hypertension"},{"name":"Chronic (medicine)","weight":0.762559,"wikipedia_article":"http://en.wikipedia.org/wiki/Chronic_(medicine)"},{"name":"Blood","weight":0.752214,"wikipedia_article":"http://en.wikipedia.org/wiki/Blood"},{"name":"Risk factor","weight":0.742555,"wikipedia_article":"http://en.wikipedia.org/wiki/Risk_factor"},{"name":"Cardiovascular disease","weight":0.741322,"wikipedia_article":"http://en.wikipedia.org/wiki/Cardiovascular_disease"},{"name":"Circulatory system","weight":0.740145,"wikipedia_article":"http://en.wikipedia.org/wiki/Circulatory_system"},{"name":"Public health","weight":0.736718,"wikipedia_article":"http://en.wikipedia.org/wiki/Public_health"},{"name":"Health","weight":0.683165,"wikipedia_article":"http://en.wikipedia.org/wiki/Health"},{"name":"Patient","weight":0.677973,"wikipedia_article":"http://en.wikipedia.org/wiki/Patient"},{"name":"Blood pressure","weight":0.677592,"wikipedia_article":"http://en.wikipedia.org/wiki/Blood_pressure"},{"name":"Pharmacotherapy","weight":0.649698,"wikipedia_article":"http://en.wikipedia.org/wiki/Pharmacotherapy"},{"name":"Risk","weight":0.611855,"wikipedia_article":"http://en.wikipedia.org/wiki/Risk"},{"name":"Therapy","weight":0.603484,"wikipedia_article":"http://en.wikipedia.org/wiki/Therapy"},{"name":"Pharmaceutical drug","weight":0.591549,"wikipedia_article":"http://en.wikipedia.org/wiki/Pharmaceutical_drug"},{"name":"Disease","weight":0.533261,"wikipedia_article":"http://en.wikipedia.org/wiki/Disease"},{"name":"Medical prescription","weight":0.402232,"wikipedia_article":"http://en.wikipedia.org/wiki/Medical_prescription"},{"name":"Health insurance","weight":0.392122,"wikipedia_article":"http://en.wikipedia.org/wiki/Health_insurance"},{"name":"Chemical substance","weight":0.336785,"wikipedia_article":"http://en.wikipedia.org/wiki/Chemical_substance"},{"name":"Infection","weight":0.254334,"wikipedia_article":"http://en.wikipedia.org/wiki/Infection"},{"name":"Amlodipine","weight":0.233635,"wikipedia_article":"http://en.wikipedia.org/wiki/Amlodipine"},{"name":"Antihypertensive drug","weight":0.169585,"wikipedia_article":"http://en.wikipedia.org/wiki/Antihypertensive_drug"},{"name":"Lead","weight":0.168449,"wikipedia_article":"http://en.wikipedia.org/wiki/Lead"},{"name":"National Health Service","weight":0.120568,"wikipedia_article":"http://en.wikipedia.org/wiki/National_Health_Service"},{"name":"Mean","weight":0.107046,"wikipedia_article":"http://en.wikipedia.org/wiki/Mean"},{"name":"Redox","weight":0.107046,"wikipedia_article":"http://en.wikipedia.org/wiki/Redox"},{"name":"Insurance","weight":0.101782,"wikipedia_article":"http://en.wikipedia.org/wiki/Insurance"},{"name":"Management","weight":0.0805305,"wikipedia_article":"http://en.wikipedia.org/wiki/Management"},{"name":"Pressure","weight":0.0805305,"wikipedia_article":"http://en.wikipedia.org/wiki/Pressure"},{"name":"Qi","weight":0.0391252,"wikipedia_article":"http://en.wikipedia.org/wiki/Qi"},{"name":"Variable (mathematics)","weight":0.0391252,"wikipedia_article":"http://en.wikipedia.org/wiki/Variable_(mathematics)"},{"name":"Hazard","weight":0.0391252,"wikipedia_article":"http://en.wikipedia.org/wiki/Hazard"},{"name":"Database","weight":0.0377168,"wikipedia_article":"http://en.wikipedia.org/wiki/Database"},{"name":"Data","weight":0.0370044,"wikipedia_article":"http://en.wikipedia.org/wiki/Data"},{"name":"Ramipril","weight":0.0342852,"wikipedia_article":"http://en.wikipedia.org/wiki/Ramipril"},{"name":"Ratio","weight":0.0300804,"wikipedia_article":"http://en.wikipedia.org/wiki/Ratio"},{"name":"Volt","weight":0.0297972,"wikipedia_article":"http://en.wikipedia.org/wiki/Volt"},{"name":"Dependent and independent variables","weight":0.0297972,"wikipedia_article":"http://en.wikipedia.org/wiki/Dependent_and_independent_variables"},{"name":"Hypertonia","weight":0.0287296,"wikipedia_article":"http://en.wikipedia.org/wiki/Hypertonia"},{"name":"Orders of magnitude (mass)","weight":0.0262143,"wikipedia_article":"http://en.wikipedia.org/wiki/Orders_of_magnitude_(mass)"},{"name":"Sleep","weight":0.0250533,"wikipedia_article":"http://en.wikipedia.org/wiki/Sleep"},{"name":"Espionage","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Espionage"},{"name":"International Organization for Standardization","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/International_Organization_for_Standardization"},{"name":"Logarithm","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Logarithm"},{"name":"Musical ensemble","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Musical_ensemble"},{"name":"Standardization","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Standardization"},{"name":"Persistent organic pollutant","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Persistent_organic_pollutant"},{"name":"Discontinuation","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Discontinuation"},{"name":"Prostitution","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Prostitution"},{"name":"Censorship","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Censorship"},{"name":"United States dollar","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/United_States_dollar"},{"name":"Mentha","weight":0.0152478,"wikipedia_article":"http://en.wikipedia.org/wiki/Mentha"},{"name":"Time","weight":0.0147415,"wikipedia_article":"http://en.wikipedia.org/wiki/Time"},{"name":"Bribery","weight":0.0147415,"wikipedia_article":"http://en.wikipedia.org/wiki/Bribery"},{"name":"Computer simulation","weight":0.0147415,"wikipedia_article":"http://en.wikipedia.org/wiki/Computer_simulation"},{"name":"State school","weight":0.0147415,"wikipedia_article":"http://en.wikipedia.org/wiki/State_school"},{"name":"Regression analysis","weight":0.0147415,"wikipedia_article":"http://en.wikipedia.org/wiki/Regression_analysis"},{"name":"International","weight":0.0147415,"wikipedia_article":"http://en.wikipedia.org/wiki/International"},{"name":"Solid","weight":0.0147415,"wikipedia_article":"http://en.wikipedia.org/wiki/Solid"},{"name":"National health insurance","weight":0.013127,"wikipedia_article":"http://en.wikipedia.org/wiki/National_health_insurance"}]}
